Applied AI and life sciences leader joins L7’s executive team to advance the L7|SYNAPSE™ Agentic AI strategy across the customer base AUSTIN, Texas — L7 Informatics, Inc., the company behind L7|ESP®, the Enterprise Science Platform that serves as an operating system for precision science, today named Ray Veeraraghavan, Ph.D., Vice President of Science and AI. Reporting to CEO […]

Peabody, Mass. — JEOL USA, Inc. has expanded its Board of Directors with the appointment of two members of its leadership team, Donna Gosselin and Steve Tryon. In addition, Dr. Thomas Isabell was appointed President of JEOL USA. Together, they bring decades of leadership experience spanning product management, applications, and field service, further strengthening the company’s […]

San Francisco, California – Yavne, Israel – Genopore, the next-generation proteomics company developing the first semiconductor based optical nanopore technology platform with AI/ML analysis for direct single protein molecule identification and digital quantification, today announced the appointment of life science leader Rey Mali as its new Chief Executive Officer, with immediate effect. Rey Mali brings more […]

this appointment reflects the company’s continued growth through investment in leadership that pairs deep scientific credibility with real-world R&D experience SAN DIEGO — Rancho BioSciences today announced the appointment of John Reynders, PhD, MBA, to its Board of Directors. In his board role, Dr. Reynders will bring strategic depth to Rancho’s product direction and growth […]

Dolsten Takes BenchSci’s First-Ever Chairman Role as EMET Scales Across Global Biopharma TORONTO — BenchSci, a leading provider of AI software for biopharma research and development, today announced the appointment of Dr. Mikael Dolsten, M.D., Ph.D., as Chairman of its Board of Directors, effective June 2026 — the first Chairman role in the company’s history. […]

SAN JOSE, Calif. — Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc. (“Takara Bio”), today announced that Carol Lou will retire as President and Chief Executive Officer of Takara Bio USA on July 10 after more than two decades with the company. Andrew Farmer, D.Phil., who has served as Chief Scientific […]

Dolsten Takes BenchSci’s First-Ever Chairman Role as EMET Scales Across Global Biopharma TORONTO — BenchSci, a leading provider of AI software for biopharma research and development, today announced the appointment of Dr. Mikael Dolsten, M.D., Ph.D., as Chairman of its Board of Directors, effective June 2026 — the first Chairman role in the company’s history. […]

New leaders bring extensive leadership experience across life sciences, diagnostics, and medical technology SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced the appointment of Mike Sullivan as Chief Commercial Officer, effective July 20, 2026, and Julie Coletti as Chief Legal Officer, effective August 3, 2026. The appointments add experienced leaders to Illumina’s Executive Leadership […]

Former Bionano Genomics Chief Medical Officer joins Nabsys at a pivotal moment as the Company expands commercialization of its electronic genome mapping platform Dr. Chaubey will lead medical and scientific affairs strategy as Nabsys works to expand global access to high-resolution structural variant analysis for cancer, constitutional, and cell and gene therapy applications PROVIDENCE, R.I. — Nabsys […]

Board Chair Maria Rankka has today notified the Board of Directors that she will step down as Board Chair and board member of BICO Group AB (publ) effective 31 July 2026. Board members Susanne Lithander and Johan Westman have also informed the Board that they will leave their Board assignments at the same time. The […]